"Shenzhen Photosynthetic Planting Co., Ltd., Enterprise profile"

1.  Enterprise origin of Photosynthetic Planting

Shenzhen Photosynthetic Planting Co., Ltd. was officially founded by David Lee on June 1, 2019. There were three reasons why Kiringo decided to set up the company.

Firstly, David Lee was engaged in the pharmaceutical industry. David Lee founded Sanke Pharmaceutical Industry and Yanwen Medicine in view of the large-scale outbreak of various chronic diseases of the aging society that China has entered in. He is promoting drug research and development in the direction of aging and chronic diseases, as well as the methods of Internet medical treatment for chronic diseases to provide better rehabilitation programs for patients. In the process, it is found that many international research and development directions for aging drugs are centered around the research and development of cannabinoid. Therefore, Sanke Pharmaceutical and Yanwen Medicine also regard the drug containing CBD as a strategic development direction.

【In recent years, many medical studies have confirmed that CBD cannabinol can be used to treat brain neurological diseases such as epilepsy, Alzheimer's disease, Parkinson's disease, insomnia and anxiety. It can prevent cerebral ischemia, reduce stroke and benefit heart protection. It has anti-cancer effect to reduce the side effects of chemotherapy and anti-inflammatory effect in the treatment of type 1 diabetes mellitus.】

Secondly, in the past three years, many countries around the world have promoted the legalization of medicinal plants. Medical plants cultivation industry is facing three major problems. The first is that the area and total output of medical plants cultivation are seriously insufficient to meet the rapid growth of market demand. The second is that the current medical plant construction investment is large and the planting cost is too high. Thirdly, the current technical level of plants growers is too low, which leads to the low content of CBD in plants leaves. This situation urgently needs an enterprise to solve the problem of insufficient supply of CBD. So David Lee set up Shenzhen Photosynthetic Planting Co., Ltd. to systematically solve the problem of insufficient supply of CBD.

Thirdly, David Lee has been engaged in international trade since 2002, mainly exporting horticultural tools and equipment. Then he also came into contact with the cultivation and extraction of a large number of biopharmaceutical raw materials. He is familiar with plants cultivation and cannabinoid extraction. So David Lee established Shenzhen Photosynthetic Planting Co., Ltd. to concentrate talents and resources and enter the pharmaceutical plants cultivation and extraction industry.

Medicines, health products and food containing CBD ingredients have begun to come on the market one after another currently. The market reaction was very good and the market grew very fast. It is expected that CBD raw materials will still be in critical shortage in the next five years. So David Lee established Shenzhen Photosynthetic Planting Co., Ltd. to reduce the cost and increase the yield of medicinal plants cultivation. We will popularize medicinal plants cultivation technology and equipment to customers who have obtained legal cultivation licenses all over the world through one-stop cultivation solutions. We will also enter the CBD extraction industry, provide advanced extraction equipment for customers who have obtained legal extraction licenses, and finally provide more and better treatment CBD raw materials for the pharmaceutical industry.

2.  Brief introduction of Shenzhen Photosynthetic Planting Co., Ltd.

Shenzhen Photosynthetic Planting Co., Ltd. applies the world's leading artificial light planting technology to the pharmaceutical medicinal plants cultivation industry. The "LED Light medicinal plants Planting Plant Program" for photosynthetic cultivation has been used by many medicinal plants planting enterprises in Canada, the United States, Spain and other countries.

The LED medicinal plants plantation plant of Photosynthetic Planting can be subdivided into "LED light medicinal plants planting plant decoration and construction plan", "medicinal plants LED various spectrum illumination time series program", "medicinal plants automatic drip irrigation time series program", "medicinal plants closed box body or space temperature, humidity, ventilation and other time series programs, "medicinal plants different growth cycle nutrient solution ratio program", "medicinal plants gardening, picking and harvesting program", and so on.

Photosynthetic Planting is also developing the cannabinoid extraction equipment at the same time, and actively carries out the extraction of cannabinoid. The company has developed a mature Cannabinoid Extraction Program and built perfect cannabinoid sales channels internationally. In addition, Photosynthetic Planting plans to jointly develop medicines, health care products and skin care products based on CBD, and further set foot in the field of drugs and consumer products in the direction of cannabinoids.

3. Core business of photosynthetic planting enterprises

The core business of Shenzhen Photosynthetic Planting Co., Ltd. is to provide the world's medical medicinal plants growers with the most advanced medicinal plants cultivation technology and equipment, the most advanced medicinal plants extraction equipment to solve the critical shortage of raw materials for medicinal plants. In the process, Photosynthetic Planting also applies for a medicinal plants cultivation license and a cannabinoid extraction license, and carry out planting and extraction operations.

Firstly, the approval procedure of planting license is very complicated. The market has not yet formed a perfect quality control standard for medicinal plants, so the developed countries that legalize medicinal plants must require enterprises to adopt greenhouse cultivation to make various factors controllable. In Canada, for example, a set of approval procedures is required for each greenhouse. Difficult planting areas and complex approval procedures make it difficult to collect the size effect, which results in insufficient supply.

Secondly, although there has been a medicinal plants fever in the capital market, a lot of investment has been invested in "medicinal plants 1.0" enterprises. However, these enterprises tend to introduce their own brands of medicinal plants consumer products or drugs in order to provide the capital market with more imagination. They are busy creating a closed-loop of commodity R&D, production and sales to form a brand effect, while ignoring the issue of raw materials shortage for medicinal plants. The business of these enterprises often does focus on the extraction and processing in the middle and lower reaches of the pharmaceutical industry and on the sales side. And it does not focus on the supply and cost of medicinal plants cultivation.

Finally, with the increasing wave of legalization of medicinal plants, more and more countries and regions have liberalized the cultivation of medicinal plants. It has led to a large number of individuals and enterprises flooding into the medicinal plants cultivation market. However, it was still in the gray area in the history, the technology and equipment for medical medicinal plants cultivation are still in a closed circle, still in a state of non-opening and opaque. This situation caused a large number of new medical medicinal plant growers encounter many difficulties and resulted in high planting costs and low production.

Therefore, Shenzhen Photosynthetic Planting Co., Ltd. provides the world's leading medicinal plants cultivation technology and equipment to help solve the current serious shortage of raw materials for medicinal plants. The core business of Shenzhen Photosynthetic Planting Co., Ltd. is as follows:

Firstly, it is to provide the world's leading and lowest-cost equipment and materials for medical plants growers. To establish a global network of online retail and wholesale of plant factories and indoor planting equipment for the world. Not only do the wholesale and retail of individual products, but also provide packaged sales and construction and installation implementation after the integration of complete equipment.

Secondly, it is to provide customers with a variety of medicinal plants, systematic planting solutions, this program will cover every stage of the growth cycle of medicinal plants. Such as "medicinal plants LED various spectrum illumination time series program", "medicinal plants automatic drip irrigation time series program", "medicinal plants closed box body or space temperature, humidity, ventilation and other time series programs, "medicinal plants different growth cycle nutrient solution ratio program", "medicinal plants gardening, picking and harvesting program", “medicinal plants dry active ingredient extraction program”, and so on.

Thirdly, Shenzhen Photosynthetic Planting Technology Co., Ltd. will provide customers with more in-depth services for medicinal plants cultivation. Its core services are as follows: planting program remote guidance service, LED medicinal plant design and construction services, 7x24 responsive service, plus camera and temperature humidity sensor, with the capability of providing customers with 7x24 hours of remote planting care.

Fourthly, we will provide customers with CBD extraction services after planting. We will build a legalized international trading platform for raw materials after harvesting of medicinal plants, and build a CBD extraction plant in a legal planting compact district. We will get involved in the post-planting transaction and extraction, and reach a joint contract responsibility system with the growers, unify the acquisition of the crude raw materials, and then transport them to our CBD extraction plant to complete the processing of CBD raw materials in the pharmaceutical industry, before the sale in the international pharmaceutical raw materials trading market.

4.  Recent development of photosynthetic planting enterprises

(1) Photosynthetic Planting is applying for medicinal plants cultivation licenses in Canada, Yunnan and Heilongjiang, that is, industrial medicinal plants cultivation licenses. With its own medicinal plants cultivation license, it is more convenient and in-depth to carry out research on medicinal plants cultivation. By the end of the year, it is expected that Photosynthetic Planting will get the planting license for 2000 medicinal plants in Canada and complete the construction of the plantation. At the same time, in the first half of next year, the medicinal plants planting license will be obtained in Yunnan.

(2) Furthermore, Photosynthetic Planting owns the mature cannabinoid extraction technology, and is applying for the extraction license of cannabinoid, aka. the industrial medicinal plants processing license. With the license, the company can grow medicinal plants and extract cannabinoid, so as to complete its industrial chain to resist market risks. On the other hand, Photosynthetic Planting can further optimize the extraction program and release Chinese-style cannabinoid extraction program. Moreover, Photosynthetic Planting has well-established cannabinoid sales channels in the world. The extracted cannabinoid products, such as CBD can be directly sold abroad for foreign exchange earning for the country.

（3）Finally, Photosynthetic Planting also hopes to carry out research and development of drugs, health products and skin care products for cannabinoid CBD. Li Peng, chairman of Photosynthetic Planting, owns two pharmaceutical companies, Sanke Pharmaceutical and Yanwen Medicine, with annual sales of about 1 billion. Photosynthetic Planting hopes to launch its own CBD-oriented products, on the one hand to meet the urgent needs of domestic consumers; on the one hand, they can also be exported abroad. To this end, Photosynthetic Planting is also investing in the planting subsidiaries and corresponding research laboratories of Photosynthetic Planting Holdings in Canada and Yunnan.

Also in News